The nephroprotective potential of selected synthetic compound against gentamicin induced nephrotoxicity.
Gentamicin
Nephroprotective
Nephrotoxicity
Synthetic compounds
Journal
BMC pharmacology & toxicology
ISSN: 2050-6511
Titre abrégé: BMC Pharmacol Toxicol
Pays: England
ID NLM: 101590449
Informations de publication
Date de publication:
27 Sep 2024
27 Sep 2024
Historique:
received:
30
04
2024
accepted:
15
07
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
Nephrotoxicity, the rapid impairment of kidney function caused by harmful drugs and chemicals, affects about 20% of cases and is projected to become a leading cause of death by reactive oxygen species (ROS). Gentamicin (GM), an aminoglycoside antibiotic is one of the well know drugs/chemicals to cause nephrotoxicity both in humans and animals. A study on the effects of a synthetic phenolic compound, called 5-a, on GM-induced nephrotoxicity in male Wistar albino rats was conducted. The rats were grouped into five groups: normal control (NC), GM control (GM), positive control (GM + Dexa), treatment I (GM + 5-a 5 mg/kg) and treatment II (GM + 5-a 10 mg/kg). Throughout the experiment, the rats' weights were monitored, and at its conclusion, their serum and kidney tissues were analyzed for renal function indicators and inflammatory markers. The study also included histopathological evaluations, molecular docking studies, blood and urine analyses for electrolyte changes, and behavioural assessments for central nervous system impact. 2-{5-[(2-hydroxyethyl)-sulfanyl]-1,3,4-oxadiazol-2-yl} phenol (5-a) significantly protected against renal damage by reducing inflammatory markers, improving antioxidant defences, and decreasing kidney injury, particularly at higher doses. The findings suggest that compound 5-a, due to its anti-inflammatory and antioxidant properties, could be a promising therapeutic option for reducing gentamicin-induced nephrotoxicity and potentially for other kidney disorders in the future. These findings highlight the therapeutic effects of compound 5-a in alleviating gentamicin-induced nephrotoxicity.
Sections du résumé
BACKGROUND
BACKGROUND
Nephrotoxicity, the rapid impairment of kidney function caused by harmful drugs and chemicals, affects about 20% of cases and is projected to become a leading cause of death by reactive oxygen species (ROS). Gentamicin (GM), an aminoglycoside antibiotic is one of the well know drugs/chemicals to cause nephrotoxicity both in humans and animals.
METHODS
METHODS
A study on the effects of a synthetic phenolic compound, called 5-a, on GM-induced nephrotoxicity in male Wistar albino rats was conducted. The rats were grouped into five groups: normal control (NC), GM control (GM), positive control (GM + Dexa), treatment I (GM + 5-a 5 mg/kg) and treatment II (GM + 5-a 10 mg/kg). Throughout the experiment, the rats' weights were monitored, and at its conclusion, their serum and kidney tissues were analyzed for renal function indicators and inflammatory markers. The study also included histopathological evaluations, molecular docking studies, blood and urine analyses for electrolyte changes, and behavioural assessments for central nervous system impact.
RESULTS
RESULTS
2-{5-[(2-hydroxyethyl)-sulfanyl]-1,3,4-oxadiazol-2-yl} phenol (5-a) significantly protected against renal damage by reducing inflammatory markers, improving antioxidant defences, and decreasing kidney injury, particularly at higher doses. The findings suggest that compound 5-a, due to its anti-inflammatory and antioxidant properties, could be a promising therapeutic option for reducing gentamicin-induced nephrotoxicity and potentially for other kidney disorders in the future.
CONCLUSION
CONCLUSIONS
These findings highlight the therapeutic effects of compound 5-a in alleviating gentamicin-induced nephrotoxicity.
Identifiants
pubmed: 39334457
doi: 10.1186/s40360-024-00765-3
pii: 10.1186/s40360-024-00765-3
doi:
Substances chimiques
Gentamicins
0
Anti-Bacterial Agents
0
Antioxidants
0
Protective Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
68Informations de copyright
© 2024. The Author(s).
Références
Al-Kuraishy HM, Al-Gareeb A, Al-Naimi MSS. Pomegranate attenuates acute gentamicin-induced nephrotoxicity in Sprague-Dawley rats: the potential antioxidant and anti-inflammatory effects. Pomegranate. 2019;12:484–6.
Al-Majed AA, Mostafa AM, Al-Rikabi AC, Al-Shabanah OA. Protective effects of oral arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacol Res. 2002;46(5):445–51.
pubmed: 12419649
doi: 10.1016/S1043661802001251
Al-Naimi MS, Rasheed HA, Hussien NR, Al-Kuraishy HM, Al-Gareeb AI. Nephrotoxicity: role and significance of renal biomarkers in the early detection of acute renal injury. J Adv Pharmaceut Tech Res. 2019;10(3):95–9.
doi: 10.4103/japtr.JAPTR_336_18
Alarifi S, Al-Doaiss A, Alkahtani S, Al-Farraj S, Al-Eissa MS, Al-Dahmash B, Al-Yahya H, Mubarak M. Blood chemical changes and renal histological alterations induced by gentamicin in rats. Saudi J Biol Sci. 2012;19(1):103–10.
pubmed: 23961168
doi: 10.1016/j.sjbs.2011.11.002
Ali B, Bashir A. Effect of superoxide dismutase treatment on gentamicin nephrotoxicity in rats. Gen Pharmacol Vasc Sys. 1996;27(2):349–53.
doi: 10.1016/0306-3623(95)02032-2
Ali BH, Al Za’abi M, Blunden G, Nemmar A. Experimental gentamicin nephrotoxicity and agents that modify it: a mini-review of recent research. Bas Clin Pharmacol Toxicol. 2011;109(4):225–32.
doi: 10.1111/j.1742-7843.2011.00728.x
Biernacki K, Daśko M, Ciupak O, Kubiński K, Rachon J, Demkowicz S. Novel 1, 2, 4-oxadiazole derivatives in drug discovery. J Pharm. 2020;13(6):111.
Çimen B, Türközkan N, Ünlü A, Erbil MK. Effects of melatonin on 3-nitrotyrosine formation and energy charge ratio in guinea pig kidney in LPS‐induced stress. Cell Biochem Funct. 2005;23(4):273–7.
pubmed: 15515121
doi: 10.1002/cbf.1151
Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, De Sarro A, Pierpaoli S, Caputi AP, Masini E. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur Pharmaco. 2002;450(1):67–76.
doi: 10.1016/S0014-2999(02)01749-1
Dawbaa S, Nuha D, Evren AE, Cankiliç MY, Yurttaş L, Turan G. New oxadiazole/triazole derivatives with antimicrobial and antioxidant properties. J Mol Struct. 2023;1282:135213.
doi: 10.1016/j.molstruc.2023.135213
De Oliveira CS, Lira BF, Barbosa-Filho JM, Lorenzo JGF, De Athayde-Filho PF. Synthetic approaches and pharmacological activity of 1, 3, 4-oxadiazoles: a review of the literature from 2000–2012. Molecules. 2012;17(9):10192–231.
pubmed: 22926303
pmcid: 6268307
doi: 10.3390/molecules170910192
Dobrek L. A synopsis of current theories on drug-induced nephrotoxicity. Life Sci. 2023;13(2):325.
El-Kashef DH, El-Kenawi AE, Rahim MA, Suddek GM, Salem HA. Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats. Can J Physiol Pharmacol. 2016;94(3):278–86.
pubmed: 26641937
doi: 10.1139/cjpp-2015-0321
Faheem M, Ali SH, Khan AW, Alam M, Ilyas U, Zahoor M, Sahibzada MUK, Khalid S, Ullah R, Alqahtani AS. 1, 3, 4-Oxadiazole derivative attenuates chronic constriction injury induced neuropathic pain: a computational, behavioral, and molecular approach. Brain Sci. 2020;10(10):731.
pubmed: 33066162
pmcid: 7601954
doi: 10.3390/brainsci10100731
Govindappa PK, Gautam V, Tripathi SM, Sahni YP, Raghavendra HLS. Effect of Withania somnifera on gentamicin induced renal lesions in rats. Rev Bras Farmacogn. 2019;29(2):234–40.
doi: 10.1016/j.bjp.2018.12.005
Goyal A, Daneshpajouhnejad P, Hashmi MF, Bashir K. Acute kidney injury. Stat Pearls. 2017.
Gu Y-Y, Zhang M, Cen H, Wu Y-F, Lu Z, Lu F, Liu X-S, Lan H-Y. Quercetin as a potential treatment for COVID-19-induced acute kidney injury: based on network pharmacology and molecular docking study. PLoS ONE. 2021;16(1):e0245209.
pubmed: 33444408
pmcid: 7808608
doi: 10.1371/journal.pone.0245209
Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am J Physiol Renal Physiol. 2007;293(1):F245–54.
doi: 10.1152/ajprenal.00477.2006
Hamash AJ, Mahmoud Zanqana AJ. Measurement of some biochemical parameters for people with toxoplasmosis. Biochem Cell Arch. 2021;21(2).
Hansen M, Christrup L, Jarløv J, Kampmann J, Bonde J. Gentamicin dosing in critically ill patients. Acta Anaesthesiol Scand. 2001;45(6):734–40.
pubmed: 11421832
doi: 10.1034/j.1399-6576.2001.045006734.x
Ho JL, Barza M. Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. Antimicrob Agent Chemother. 1987;31(4):485–91.
doi: 10.1128/AAC.31.4.485
Holzhaider JC, Sibley MD, Taylor AH, Singh PJ, Gray RD, Hunt GR. The social structure of New Caledonian crows. Anim Behav. 2011;81(1):83–92.
doi: 10.1016/j.anbehav.2010.09.015
Ijaz M, Majeed S, Asharaf A, Ali T, Al-Ghanim K, Asad F, Zafar S, Ismail M, Samad A, Ahmed Z. Toxicological effects of thimerosal on rat kidney: a histological and biochemical study. Brazilian J Biol. 2021;83:e242942.
doi: 10.1590/1519-6984.242942
Imran M, Al Kury LT, Nadeem H, Shah FA, Abbas M, Naz S, Khan A-U, Li S. Benzimidazole containing acetamide derivatives attenuate neuroinflammation and oxidative stress in ethanol-induced neurodegeneration. Biomolecules. 2020;10(1):108.
pubmed: 31936383
pmcid: 7023260
doi: 10.3390/biom10010108
Jörg M, Agostino M, Yuriev E, Mak FS, Miller ND, White JM, Scammells PJ, Capuano B. Synthesis, molecular structure, NMR spectroscopic and computational analysis of a selective adenosine a 2A antagonist, ZM 241385. Struct Chem. 2013;24:1241–51.
doi: 10.1007/s11224-012-0151-7
Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Prim. 2021;7(1):52.
pubmed: 34267223
doi: 10.1038/s41572-021-00284-z
Khan AM, Khan AU, Ali H, Islam SU, Seo EK, Khan S. Continentalic acid exhibited nephroprotective activity against the LPS and E. Coli-induced kidney injury through inhibition of the oxidative stress and inflammation. Int Immunopharmacol. 2020;L80:106209.
doi: 10.1016/j.intimp.2020.106209
Kwiatkowska E, Domański L, Dziedziejko V, Kajdy A, Stefańska K, Kwiatkowski S. The mechanism of drug nephrotoxicity and the methods for preventing kidney damage. Int J Mol Sci. 2021;22(11):6109.
pubmed: 34204029
pmcid: 8201165
doi: 10.3390/ijms22116109
Lucas GNC, Leitao ACC, Alencar RL, Xavier RMF, Daher EDF, Silva, GBd. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. Brazilian J Nephrol. 2021;41:124–30.
doi: 10.1590/2175-8239-jbn-2018-0107
Martínez-Salgado C, Eleno N, Morales AI, Pérez-Barriocanal F, Arévalo M, López-Novoa JM. Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats. Kidney Int. 2004;65(6):2161–71.
pubmed: 15149329
doi: 10.1111/j.1523-1755.2004.00642.x
Metin TO, Bayrak G, Yaman S, Doganer A, Yoldas A, Eser N, Aykan DA, Yilmaz BC, Kurt AH, Ayaz L. Expression of ER stress markers (GRP78 and PERK) in experimental nephrotoxicity induced by cisplatin and gentamicin: roles of inflammatory response and oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(4):789–801.
pubmed: 36482225
doi: 10.1007/s00210-022-02358-5
Mishra P, Mandlik D, Arulmozhi S, Mahadik K. Nephroprotective role of diosgenin in gentamicin-induced renal toxicity: biochemical, antioxidant, immunological and histopathological approach. Future J Pharm Sci. 2021;7(1):1–13.
Naughton CA. Drug-induced nephrotoxicity. Ame Fam Phy. 2008;78(6):743–50.
Noushida N, Shenoy PJ, Rao RR, Teerthanath S. Nephroprotective activity of betulinic acid in gentamicin induced murine model of renotoxicity. Res J Pharm Technol. 2020;13(3):1391–6.
doi: 10.5958/0974-360X.2020.00255.3
Pedraza-Chaverrı́ J, González-Orozco AE, Maldonado PD, Barrera D, Medina-Campos ON, Hernández-Pando R. Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats. Eur J Pharmacol. 2003;473(1):71–8.
pubmed: 12877940
doi: 10.1016/S0014-2999(03)01948-4
Rocha MP, Mentetzides SH, Drew RC. Renal blood flow during exercise: understanding its measurement with doppler ultrasound. J Appl Phys. 2023;134(4):1004–10.
Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013;83(6):1029–41.
pubmed: 23325084
pmcid: 3633725
doi: 10.1038/ki.2012.439
Seemab K, Khan A-U, Khan MI, Qazi NG, Minhas AM, Ali F. Anti-pruritic effect of l carnitine against chloroquine-induced pruritus mediated via nitric oxide pathway. BMC Pharmacol Toxicol. 2024;25(1):32.
pubmed: 38778384
pmcid: 11110330
doi: 10.1186/s40360-024-00748-4
Sharma RK, Rajani G, Sharma V, Komala N. Effect of ethanolic and aqueous extracts of Bauhinia variegata Linn. on gentamicin-induced nephrotoxicity in rats. Indian J Pharm Educ Res. 2011;45(2):192–8.
Sodimbaku V, Pujari L, Mullangi R, Marri S. Carrot (Daucus carota L.): nephroprotective against gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol. 2016;48(2):122–7.
pubmed: 27127313
pmcid: 4825426
doi: 10.4103/0253-7613.178822
Somani RR, Shirodkar PY. Oxadiazole: a biologically important heterocycle. ChemInform. 2011;42(10). https://doi.org/10.1002/chin.201110251
Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measured and estimated glomerular filtration rate. New Eng J Med. 2006;354(23):2473–83.
doi: 10.1056/NEJMra054415
Thapa S, Nargund SL, Biradar MS, Banerjee J, Karati D. In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation. Inf Med Unlock. 2023;38:101213.
doi: 10.1016/j.imu.2023.101213
Vollmayr B, Henn FA. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Protoc. 2001;8(1):1–7.
doi: 10.1016/S1385-299X(01)00067-8
Zhu W, Wang W, Shi Y, Shen B, Li Y. Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature. Virchows Arch. 2023;483(4):561–7.
pubmed: 37101053
pmcid: 10611822
doi: 10.1007/s00428-023-03545-2